M2 Pharma - Therapy Areas

FDA Approves Expanded Use of Adacel Vaccine for Repeat Vaccination

15 January 2019 - - The US Food and Drug Administration has approved the expanded use of Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed) to include rep...

iReceptor Plus reports launch of international consortium project to promote human immunological data storage, integration and controlled sharing

15 January 2019 - iReceptor Plus stated on Tuesday that European Union (EU) and the Canadian government have awarded EUR8.4m under its international consortium project to promote human immunological d...

Sanofi wins US FDA approval for expanded repeat vaccination of Adacel against tetanus, diphtheria and pertussis

15 January 2019 - Biopharmaceutical company Sanofi reported on Monday the receipt of approval from the US Food and Drug Administration for the expanded use of Adacel (Tetanus Toxoid, Reduced Diphtheri...

hVIVO's phase II vaccine flu study reveals positive result

14 January 2019 - hVIVO, a specialty biopharma company, has revealed positive results for the primary endpoint, following completion of analysis of samples by the National Institute of Allergy and Inf...

ALK-Abelló appoints Christian Houghton as new head of Product Supply

14 January 2019 - ALK Abelló (ALK) (CPH:ALKB), a global specialty pharmaceutical company focused on allergy and allergic asthma, announced on Friday that it has appointed Christian G. Houghton ...

Tivic Health wins US FDA's 510(k) clearance for ClearUP for the treatment of sinus pain associated with allergic rhinitis/hay fever

4 January 2019 - Bioelectronic device company Tivic Health Systems Inc reported on Thursday the receipt of the 510(k) clearance from the US Food and Drug Administration (FDA) for the first-in-class bi...